farnesol has been researched along with Angiomyolipoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrlich, M; Gefen-Dor, C; Jacob-Hirsch, J; Kloog, Y; Makovski, V; Rechavi, G; Shai, B | 1 |
1 other study(ies) available for farnesol and Angiomyolipoma
Article | Year |
---|---|
Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
Topics: Angiomyolipoma; Cell Proliferation; Farnesol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Interferon Regulatory Factor-7; Kidney; Lymphangioleiomyomatosis; Microarray Analysis; Monomeric GTP-Binding Proteins; Neuropeptides; Ras Homolog Enriched in Brain Protein; RNA, Small Interfering; Salicylates; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2014 |